Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) Research & Development: 2021-2024

Historic Research & Development for Journey Medical (DERM) over the last 4 years, with Dec 2024 value amounting to $9.9 million.

  • Journey Medical's Research & Development fell 65.91% to $287,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 87.56%. This contributed to the annual value of $9.9 million for FY2024, which is 30.71% up from last year.
  • Journey Medical's Research & Development amounted to $9.9 million in FY2024, which was up 30.71% from $7.5 million recorded in FY2023.
  • In the past 5 years, Journey Medical's Research & Development ranged from a high of $10.9 million in FY2022 and a low of $2.7 million during FY2021.
  • Moreover, its 3-year median value for Research & Development was $9.9 million (2024), whereas its average is $9.4 million.
  • In the last 5 years, Journey Medical's Research & Development surged by 299.53% in 2022 and then plummeted by 31.09% in 2023.
  • Over the past 4 years, Journey Medical's Research & Development (Yearly) stood at $2.7 million in 2021, then spiked by 299.53% to $10.9 million in 2022, then plummeted by 31.09% to $7.5 million in 2023, then skyrocketed by 30.71% to $9.9 million in 2024.